CRISPINA CALSADA

Insider Reports History

Location
San Diego, CA
Signature
/s/ Christopher Aker, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by CRISPINA CALSADA:

Company Role Class Num Shares Value Price $ Report Date Ownership
Regulus Therapeutics Inc. Chief Financial Officer Common Stock 0 $0 $7.87 25 Jun 2025 Direct
Regulus Therapeutics Inc. Chief Financial Officer Stock Option (Right to Buy) 562,500 30 Jan 2025 Direct
Regulus Therapeutics Inc. Chief Financial Officer Stock Option 0 25 Jun 2025 Direct

Insider Reports Filed by CRISPINA CALSADA

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RGLS Regulus Therapeutics Inc. 25 Jun 2025 11 $0 4 Chief Financial Officer 27 Jun 2025, 16:58
RGLS Regulus Therapeutics Inc. 30 Jan 2025 1 $0 4 Chief Financial Officer 31 Jan 2025, 17:00
RGLS Regulus Therapeutics Inc. 13 Jan 2025 2 -$55,333 4 Chief Financial Officer 15 Jan 2025, 17:00
RGLS Regulus Therapeutics Inc. 09 Jan 2025 2 +$112,300 4 Chief Financial Officer 10 Jan 2025, 17:00
RGLS Regulus Therapeutics Inc. 20 May 2024 1 $0 4 Chief Financial Officer 21 May 2024, 16:21
RGLS Regulus Therapeutics Inc. 18 Jan 2024 1 -$6,510 4 Chief Financial Officer 18 Jan 2024, 20:24
RGLS Regulus Therapeutics Inc. 12 Jan 2024 2 $0 4 Chief Financial Officer 17 Jan 2024, 17:08
RGLS Regulus Therapeutics Inc. 10 Aug 2023 1 $0 4 Chief Financial Officer 14 Aug 2023, 17:19
RGLS Regulus Therapeutics Inc. 11 Jan 2023 1 $0 4 Chief Financial Officer 17 Jan 2023, 15:10
RGLS Regulus Therapeutics Inc. 10 May 2022 1 $0 4 Chief Financial Officer 11 May 2022, 16:34
RGLS Regulus Therapeutics Inc. 12 Jan 2022 1 $0 4 Chief Financial Officer 26 Jan 2022, 15:12